Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biosource International -- Ignore unavailable to you. Want to Upgrade?

To: Night Trader who wrote (330)	11/18/1997 6:42:00 PM
From: Joe Dancy	Read Replies (1) \| Respond to of 696

Dave said some of his medical buddies liked BIOI's products - now whether they liked them better than Techne or Genzyme I don't know - although like Dave says Techne is selling at a PE of 30, and Genzyme is into a lot of other stuff. Dave says that the new molecular diagnostic products will go over well according to this industry sources. Some of the current test kit technology while still state of the art is getting dated - but that cuts across all the companies. Let me know what feedback you get from customers. One problem is that a lot of their sales is now in Europe, and while I assume they have the same reaction as researchers over here in the U.S. they may also be focusing on different technologies/development strategies. Joe